- Home
- TERN vs VINP Comparison
TERN vs VINP Comparison
Compare TERN & VINP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TERN
- VINP
- Stock Information
- Founded
- TERN 2017
- VINP 2009
- Country
- TERN United States
- VINP Brazil
- Employees
- TERN N/A
- VINP N/A
- Industry
- TERN Biotechnology: Pharmaceutical Preparations
- VINP Investment Managers
- Sector
- TERN Health Care
- VINP Finance
- Exchange
- TERN Nasdaq
- VINP Nasdaq
- Market Cap
- TERN 586.0M
- VINP 694.1M
- IPO Year
- TERN 2021
- VINP 2021
- Fundamental
- Price
- TERN $6.17
- VINP $10.34
- Analyst Decision
- TERN Buy
- VINP Strong Buy
- Analyst Count
- TERN 6
- VINP 2
- Target Price
- TERN $16.42
- VINP $14.50
- AVG Volume (30 Days)
- TERN 1.3M
- VINP 60.0K
- Earning Date
- TERN 11-12-2024
- VINP 11-07-2024
- Dividend Yield
- TERN N/A
- VINP 6.58%
- EPS Growth
- TERN N/A
- VINP N/A
- EPS
- TERN N/A
- VINP 0.60
- Revenue
- TERN N/A
- VINP $88,217,697.00
- Revenue This Year
- TERN N/A
- VINP $7.69
- Revenue Next Year
- TERN N/A
- VINP $11.35
- P/E Ratio
- TERN N/A
- VINP $17.28
- Revenue Growth
- TERN N/A
- VINP 9.03
- 52 Week Low
- TERN $3.59
- VINP $9.01
- 52 Week High
- TERN $11.40
- VINP $11.85
- Technical
- Relative Strength Index (RSI)
- TERN 31.82
- VINP 49.61
- Support Level
- TERN $6.99
- VINP $10.51
- Resistance Level
- TERN $7.53
- VINP $10.95
- Average True Range (ATR)
- TERN 0.47
- VINP 0.29
- MACD
- TERN -0.02
- VINP 0.00
- Stochastic Oscillator
- TERN 16.57
- VINP 32.29
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.
About VINP Vinci Partners Investments Ltd.
Vinci Partners Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Market; Liquid Strategies; Investment Products and solutions; Financial Advisory; and Retirement Services. The company's majority of its revenue comes from the Private Market segment which is comprised of five business lines: private equity, real estate, infrastructure, credit, and special situations.